Back
NovaBay Pharmaceuticals Vs. Root Industry Stock Comparison
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
$0.63
Seasonality Move:
-8.46%
Buy
83
ROOT
Root
Last Price:
$151.70
Seasonality Move:
13.8%
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.63. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.63The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.45 | Buy |
Chaikin Money Flow: | -25667 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.66) | Buy |
Bollinger Bands (100): | (0.57 - 0.71) | Sell |
ROOT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.69 | Buy |
Relative Strength Index (14 RSI): | 64.6 | Buy |
Chaikin Money Flow: | 1140316 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.14 - 137.86) | Buy |
Bollinger Bands (100): | (62.74 - 116.06) | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Buy |
20-day SMA: | 0.63 | Buy |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 1.07 | Sell |
8-day EMA: | 0.62 | Buy |
20-day EMA: | 0.63 | Buy |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 3.03 | Sell |
ROOT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.59 | Buy |
20-day SMA: | 126.37 | Buy |
50-day SMA: | 103.59 | Buy |
200-day SMA: | 69.6 | Buy |
8-day EMA: | 137.15 | Buy |
20-day EMA: | 126.75 | Buy |
50-day EMA: | 109.94 | Buy |
200-day EMA: | 75.85 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Root Earnings Growth & ROOT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.83 per share, an increase next quarter of $0.41 per share, a decrease this year of $0.33 per share, and an increase next year of $2.11 per share.
NovaBay Pharmaceuticals Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Root Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |